And, you know, historically since, I don't know, like, 2018 to present, you s- there's been quite a bit of consolidation and rearrangement in, in the industry.

Yeah, and I would add to that operationally, aside from, you know, an infusion pharmacy and the associated clinic has all of the operational issues that a normal pharmacy does, and then there are issues that are nuanced in particular to the fact that they're doing infusion or perhaps delivering the infusion, administering the infusion to a patient in a suite that may be adjacent to the pharmacy or may be entirely disconnected from the pharmacy.

So we see site licensure issues, we see drug storage issues, compounding issues, chain of custody issues related to who can possess the drug, and even scope of practice issues with whether it's a nurse practitioner or a mere RN that's doing the infusion.

And again, that all comes together as possession of the drug, storage of the drug, and site licensure.

if you don't mind, uh, don't mind expanding on that, that'd be interesting.

Yeah.

I mean, I think the, the regulatory diligence for a transaction involving an infusion pharmacy r- really is checking the underlying regulatory compliance.

I mean, is the pharmacy operating with the licensure it needs? Is it operating according to the standards that govern its practice? Is everyone...